Tanja M. Liebig

Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein

Julia Stieglmaier, Edwin Bremer, Christian Kellner et al. · Cancer Immunology Immunotherapy · 2007 · 62 citations · Full text

Lymphoid Neoplasia, Leukemic B-lymphoid Cells, Apoptosis +8

The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells

Alexander Shimabukuro‐Vornhagen, Andreas Draube, Tanja M. Liebig et al. · Journal of Experimental & Clinical Cancer Research · 2012 · 52 citations · Full text

Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity

Alexander Shimabukuro‐Vornhagen, Shahram Zoghi, Tanja M. Liebig et al. · The Journal of Immunology · 2014 · 39 citations

T-regulatory Cell, Immunology, Immune Regulation +20

Generation of Human CD40-activated B cells

Tanja M. Liebig, Anne Fiedler, Shahram Zoghi et al. · Journal of Visualized Experiments · 2009 · 36 citations · Full text

The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect

Alexander Shimabukuro‐Vornhagen, Tanja M. Liebig, Thomas C. Koslowsky et al. · Cellular Immunology · 2013 · 22 citations

Inflammation, Prostaglandin E2, Signal Transduction +15